Ethical issues in preconception genetic screening
Today, we are given numerous reproductive options. This is making couples feel more responsible for making the right choice: A choice that depends not only on their medical and genetic status, but also on their beliefs and their moral outlook.
Preconception genetic screening (PCS) has been offered to for families with recessive genetic diseases. It has also been offered to communities with high prevalence of severe genetic disorders (for example Ashkenazi Jews).
The tests have become more reliable and cost effective, making it possible to consider genetic screening for carrier status in populations. This has led to an ethical debate: On one hand, preconception genetic screening could increase the reproductive choices for individuals or couples and lead to enhanced reproductive autonomy. On the other hand, it is not necessarily so that more choice enhances autonomy. Too much choice can lead to moral distress. The debate has also revolved around the possible medicalization of the reproductive process that preconception genetic screening can lead to.
Aims
This project will:
- Explore the ethical issues of preconception genetic screening, taking the family’s and the individual's perspective into account.
- Focus on the interface between health care providers (for example clinical geneticists and gynecologists) and the prospective parents/family.
- Highlight the role and responsibility of family members and health care providers in the decision making process regarding preconception genetic screening.
Format
PhD project
Time table
2013-2017
Contact
- Amal Matar, MD, MSc, PhD Student
Supervisors
- Anna T. Höglund, Associate Professor of Ethics
- Mats G. Hansson, Professor of Biomedical Ethics
Clinical ethics
We are interested in the ethical issues that arise in clinical settings: In association with diagnosis, treatment and the organization and delivery of health care
Risk information
We are investigating risk information from serval perspectives.
Handling incidental findings
How should we handle incidental findings in biobank and -omics research? Jennifer Viberg Johansson's PhD project examined the arguments for and against disclosure of incidental findings.